Clinical, Experimental, and Genomic Differences between Intermediately Pathogenic, Highly Pathogenic, and EpidemicStreptococcus suis
The Journal of Infectious Diseases2008Vol. 199(1), pp. 97–107
Citations Over TimeTop 10% of 2008 papers
Changyun Ye, Han Zheng, Ji Zhang, Huaiqi Jing, Lei Wang, Yanwen Xiong, Wei Wang, Zhemin Zhou, Qiangzheng Sun, Xia Luo, Huamao Du, Marcelo Gottschalk, Jianguo Xu
Abstract
Intermediately pathogenic strain ST25 has evolved to become highly pathogenic strain ST1, which, in turn, has more recently evolved to become epidemic strain ST7. ST7 has the ability to stimulate the production of massive amounts of proinflammatory cytokines, leading to STSLS.
Related Papers
- → Characterization and functional analysis of PnuC that is involved in the oxidative stress tolerance and virulence of Streptococcus suis serotype 2(2018)32 cited
- → Studies on a murine model for evaluation of virulence ofStreptococcus suiscapsular type 2 isolates(1992)36 cited
- → Murine and Pig Models of Streptococcus suis Type 2 Infections Are Incompatible(1997)7 cited
- → Studies on a murine model for evaluation of virulence of Streptococcus suis capsular type 2 isolates(1992)1 cited